Center for Care Delivery and Outcomes Research, Minneapolis VA Health Care System, Minneapolis, MN.
Department of Psychiatry, University of Minnesota Medical School, Minneapolis, MN.
Behav Sleep Med. 2021 Sep-Oct;19(5):629-639. doi: 10.1080/15402002.2020.1828085. Epub 2020 Oct 16.
OBJECTIVE/BACKGROUND: Cognitive behavioral therapy for insomnia (CBT-I) provides safe and effective insomnia care without the risk of harm associated with sleeping medications. Unfortunately, few patients with insomnia engage with CBT-I, with most using sedative hypnotics instead. This study conducted focus groups with patients with insomnia who were treated with sleeping medication, including older adults, women, and patients with chronic pain. The goal was to explore the perspectives of high-risk, CBT-I naïve patients on increasing access and engagement with CBT-I.
Participants included 29 Veterans with insomnia who had been prescribed sleeping medication in the last year and had not previously engaged with CBT-I.
Semi-structured 90-min focus groups were used to 1) explore messages and appropriate channels for a CBT-I social marketing campaign, 2) determine patient preferences for self-management CBT-I tools, and 3) determine patient opinions on alternative provider-delivered forms of CBT-I. Thematic analysis was used to identify conceptual themes.
Three main themes were identified. First, patient education is necessary but not sufficient. Patients recommended multiple outreach attempts through multiple channels to motivate tired and overwhelmed insomnia patients to engage with CBT-I. Second, patients gravitated toward a stepped-care approach. Most would start with self-management CBT-I tools, moving on to provider-delivered CBT-I if needed. Finally, patients appreciated being able to choose from a menu of CBT-I delivery options and would use multiple options simultaneously.
These findings suggest promising opportunities to increase the use of CBT-I for high-risk patients through patient education and provision of self-management CBT-I tools.
目的/背景:认知行为疗法治疗失眠症(CBT-I)为失眠症患者提供了安全有效的治疗方法,且不会像镇静催眠药物那样带来伤害风险。然而,接受 CBT-I 治疗的失眠症患者人数仍然较少,大多数患者还是选择使用镇静催眠药物。本研究对正在接受睡眠药物治疗的失眠症患者(包括老年患者、女性患者和慢性疼痛患者)进行了焦点小组访谈,旨在探讨对高风险、初次接受 CBT-I 治疗的患者增加 CBT-I 治疗可及性和参与度的看法。
共有 29 名失眠症退伍军人参与研究,他们在过去一年中曾被开具过睡眠药物处方,但此前并未接受过 CBT-I 治疗。
采用 90 分钟的半结构式焦点小组访谈,以探讨 1)CBT-I 社会营销活动的信息和适当渠道;2)患者对自我管理 CBT-I 工具的偏好;3)患者对替代提供的 CBT-I 形式的看法。采用主题分析法识别概念主题。
确定了三个主要主题。首先,患者教育是必要的,但还不够。患者建议通过多种渠道进行多次外联尝试,以激励疲倦和不知所措的失眠症患者接受 CBT-I 治疗。其次,患者倾向于采用阶梯式治疗方法。大多数患者会从自我管理 CBT-I 工具开始,如果需要的话,再过渡到由提供者提供的 CBT-I。最后,患者希望能够从 CBT-I 治疗方法菜单中进行选择,并同时使用多种方法。
这些发现表明,通过患者教育和提供自我管理 CBT-I 工具,为高风险患者增加 CBT-I 的使用具有很大的潜力。